|
|||||
|
|
Activated leukocyte cell adhesion molecule in breast cancer: prognostic indicator |
|
| Authors: | Judy A King Solomon F Ofori-Acquah Troy Stevens Abu-Bakr Al-Mehdi Oystein Fodstad Wen G Jiang |
| Affiliation: | (1) Department of Pathology, University of South Alabama, Mobile, Alabama, USA;(2) Department of Pharmacology, University of South Alabama, Mobile, Alabama, USA;(3) Center for Lung Biology, University of South Alabama, Mobile, Alabama, USA;(4) Department of Cell Biology and Neuroscience, University of South Alabama, Mobile, Alabama, USA;(5) Cancer Research Institute, University of South Alabama, Mobile, Alabama, USA;(6) Department of Surgery, University of Wales College of Medicine, Cardiff, UK |
| Abstract: | IntroductionActivated leukocyte cell adhesion molecule (ALCAM) (CD166) is an immunoglobulin molecule that has been implicated in cell migration. The present study examined the expression of ALCAM in human breast cancer and assessed its prognostic value. |
| Keywords: | ALCAM breast cancer metastasis prognosis |
| 本文献已被 PubMed SpringerLink 等数据库收录！ | |